Show simple item record

dc.contributor.authorBowen, A
dc.contributor.authorMani, Navin
dc.contributor.authorPenney, S
dc.contributor.authorLoughran, S
dc.contributor.authorYap, Beng K
dc.date.accessioned2015-07-01T07:50:39Zen
dc.date.available2015-07-01T07:50:39Zen
dc.date.issued2015-05en
dc.identifier.citationSurgical management of medullary thyroid cancer: which guidelines should we follow? 2015, 129 (5):478-83 J Laryngol Otolen
dc.identifier.issn1748-5460en
dc.identifier.pmid25994382en
dc.identifier.doi10.1017/S0022215115000237en
dc.identifier.urihttp://hdl.handle.net/10541/558736en
dc.description.abstractSurgery is currently the only curative treatment for medullary thyroid cancer. Unfortunately, the surgical strategy that will offer patients at each disease stage the best chance of a biochemical cure remains unclear. The American Thyroid Association and British Thyroid Association guidelines offer different strategies.
dc.language.isoenen
dc.rightsArchived with thanks to The Journal of laryngology and otologyen
dc.titleSurgical management of medullary thyroid cancer: which guidelines should we follow?en
dc.typeArticleen
dc.contributor.departmentDepartment of ENT,Central Manchester NHS Foundation Trust,Manchester,UKen
dc.identifier.journalThe Journal of Laryngology and Otologyen
html.description.abstractSurgery is currently the only curative treatment for medullary thyroid cancer. Unfortunately, the surgical strategy that will offer patients at each disease stage the best chance of a biochemical cure remains unclear. The American Thyroid Association and British Thyroid Association guidelines offer different strategies.


This item appears in the following Collection(s)

Show simple item record